MiR‐129‐5p promotes docetaxel resistance in prostate cancer by down‐regulating CAMK2N1 expression
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR‐129‐5p promotes docetaxel resistance in prostate cancer by down‐regulating
CAMK2N1
expression
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 24, Issue 3, Pages 2098-2108
Publisher
Wiley
Online
2019-12-26
DOI
10.1111/jcmm.14050
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LncRNA HIF1A-AS2 positively affects the progression and EMT formation of colorectal cancer through regulating miR-129-5p and DNMT3A
- (2018) Jinguan Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control
- (2018) Cinzia Antognelli et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNA-337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways
- (2017) Xuerong Liu et al. ONCOLOGY REPORTS
- Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by hsa-miR-125a-3p via Modulation of Metastasis-Associated Protein 1 Signaling
- (2017) Jian-zhou Liu et al. UROLOGY
- Role of protein S in castration-resistant prostate cancer-like cells
- (2016) Peng Ning et al. ENDOCRINE-RELATED CANCER
- Radioimmunotherapy for Prostate Cancer—Current Status and Future Possibilities
- (2016) Susan Evans-Axelsson et al. SEMINARS IN NUCLEAR MEDICINE
- miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110
- (2016) Irene V. Bijnsdorp et al. Oncotarget
- Norcantharidin induces autophagy-related prostate cancer cell death through Beclin-1 upregulation by miR-129-5p suppression
- (2015) Wenjun Xiao et al. TUMOR BIOLOGY
- MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition
- (2015) Yuan Zhang et al. Scientific Reports
- The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer
- (2015) Tao Wang et al. Oncotarget
- Calcium/Calmodulin-Dependent Protein Kinase II and Its Endogenous Inhibitor in Medullary Thyroid Cancer
- (2014) E. Russo et al. CLINICAL CANCER RESEARCH
- miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression
- (2013) MIN KANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC
- (2013) MingHua Li et al. PLoS One
- miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer
- (2013) M Karaayvaz et al. Cell Death & Disease
- VCP/p97, Down-Regulated by microRNA-129-5p, Could Regulate the Progression of Hepatocellular Carcinoma
- (2012) Yu Liu et al. PLoS One
- CpG island methylation status of miRNAs in esophageal squamous cell carcinoma
- (2011) Xuedan Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer
- (2011) Kuo-Wang Tsai et al. INTERNATIONAL JOURNAL OF CANCER
- Spatiotemporal Regulation of Multiple Overlapping Sense and Novel Natural Antisense Transcripts at the Nrgn and Camk2n1 Gene Loci during Mouse Cerebral Corticogenesis
- (2010) King-Hwa Ling et al. CEREBRAL CORTEX
- Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells
- (2010) N Bhatnagar et al. Cell Death & Disease
- Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR
- (2009) Ryo Ogawa et al. Medical Molecular Morphology
- A Novel Endogenous Human CaMKII Inhibitory Protein Suppresses Tumor Growth by Inducing Cell Cycle Arrest via p27 Stabilization
- (2008) Chunmei Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More